Ryoko Friday, 04/12/19 06:54:52 PM Re: None Post # of 750 I'm a little surprised the price mostly held today given there's no longer an FDA ace in the hole to play, at least not for while. A poster on another forum claimed he had called AVGR's IR and was told there was no dilution from the company in recent days. This suggests someone played a ton of warrants. This is also kinda bad news because it means the shelf offering is still in the wings waiting to strike. Plus we get to look forward to an RS. Yes, they got FDA approval, but it's going to take a while before they start seeing meaningful revenue from it. With all this, I'll say again that I'm surprised the price didn't continue to plummet.